# DIORASIS THERAPEUTICS CORPORATION: Gene therapy to normalize intraocular pressure for the treatment of juvenile open angle glaucoma

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | DIORASIS THERAPEUTICS CORPORATION |
| Location | Watertown, MA |
| Project | Gene therapy to normalize intraocular pressure for the treatment of juvenile open angle glaucoma |
| Project number | 1R44EY039191-01 |
| Mechanism | R44 |
| Institute | National Eye Institute |
| Award | $758,533 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-30 to 2028-05-31 |
| UEI | P9NFFNZH4313 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11409527). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.